384 related articles for article (PubMed ID: 24619853)
1. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of serum CA19-9 as a prognostic factor for the ampulla of Vater carcinoma.
Kurihara C; Yoshimi F; Sasaki K; Iijima T; Kawasaki H; Nagai H
Hepatogastroenterology; 2013 Oct; 60(127):1588-91. PubMed ID: 23933785
[TBL] [Abstract][Full Text] [Related]
4. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
5. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
[TBL] [Abstract][Full Text] [Related]
6. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
[TBL] [Abstract][Full Text] [Related]
7. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections.
Duffy JP; Hines OJ; Liu JH; Ko CY; Cortina G; Isacoff WH; Nguyen H; Leonardi M; Tompkins RK; Reber HA
Arch Surg; 2003 Sep; 138(9):941-8; discussion 948-50. PubMed ID: 12963649
[TBL] [Abstract][Full Text] [Related]
8. Ampullary cancer and preoperative jaundice: possible indication of the minimal surgery.
Uchida H; Shibata K; Iwaki K; Kai S; Ohta M; Kitano S
Hepatogastroenterology; 2009; 56(93):1194-8. PubMed ID: 19760968
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the two histological subtypes of ampullary adenocarcinoma: a retrospective study.
Xu ZY; Guan J; Zhang ZY; Liu DW; Li XD; Zhou ZQ
Cir Cir; 2024; 92(2):159-164. PubMed ID: 38782386
[TBL] [Abstract][Full Text] [Related]
10. Pathological factors influencing survival of carcinoma of the ampulla of Vater.
Mori K; Ikei S; Yamane T; Yamaguchi Y; Katsumori T; Shibata Y; Arai T
Eur J Surg Oncol; 1990 Jun; 16(3):183-8. PubMed ID: 2347413
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing lymph node metastasis in patients with ampullary adenocarcinoma.
Okano K; Asano E; Kushida Y; Kamada H; Mori H; Suzuki Y
Dig Surg; 2014; 31(6):459-67. PubMed ID: 25613423
[TBL] [Abstract][Full Text] [Related]
12. Significance analysis of histologic type and perineural invasion as prognostic factors after curative resection of ampulla of Vater carcinoma.
Lee JH; Lee KG; Ryou H; Jun YJ; Paik SS; Park HK; Lee KS
Hepatogastroenterology; 2010; 57(99-100):646-52. PubMed ID: 20698243
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma.
Sudo T; Murakami Y; Uemura K; Hayashidani Y; Hashimoto Y; Ohge H; Shimamoto F; Sueda T
Dig Dis Sci; 2008 Aug; 53(8):2281-6. PubMed ID: 18095164
[TBL] [Abstract][Full Text] [Related]
14. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
[TBL] [Abstract][Full Text] [Related]
15. Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric study.
Robert PE; Leux C; Ouaissi M; Miguet M; Paye F; Merdrignac A; Delpero JR; Schwarz L; Carrere N; Muscari F; Gayet B; Dussart D; Hamy A; Regenet N
Pancreas; 2014 Jul; 43(5):692-7. PubMed ID: 24713843
[TBL] [Abstract][Full Text] [Related]
16. A survival predictive model in patients undergoing radical resection of ampullary adenocarcinoma.
Wang CH; Mo LR; Lin RC; Kuo JJ; Chang KK; Lin YW; Yang DM; Yau MP; Cho CY
Hepatogastroenterology; 2004; 51(59):1495-9. PubMed ID: 15362785
[TBL] [Abstract][Full Text] [Related]
17. Perineural invasion and preoperative serum CA19-9 as predictors of survival in biliary tract cancer.
Kawamata H; Yamashita K; Nakamura K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Kumamoto Y; Watanabe M
Anticancer Res; 2013 Feb; 33(2):583-94. PubMed ID: 23393352
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic characterization and clinical outcome in ampullary adenocarcinoma.
Asano E; Okano K; Oshima M; Kagawa S; Kushida Y; Munekage M; Hanazaki K; Watanabe J; Takada Y; Ikemoto T; Shimada M; Suzuki Y;
J Surg Oncol; 2016 Jul; 114(1):119-27. PubMed ID: 27132476
[TBL] [Abstract][Full Text] [Related]
19. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
20. Pathologic Subtypes of Ampullary Adenocarcinoma: Value of Ampullary MDCT for Noninvasive Preoperative Differentiation.
Ivanovic AM; Alessandrino F; Maksimovic R; Micev M; Ostojic S; Gore RM; Mortele KJ
AJR Am J Roentgenol; 2017 Mar; 208(3):W71-W78. PubMed ID: 28095024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]